Glaxosmithkline Pharmaceuticals informs about financial results

25 Jul 2017 Evaluate

Glaxosmithkline Pharmaceuticals has informed about Un-Audited Standalone Financial Results for first quarter ended June 30, 2017.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

1899.00 -0.85 (-0.04%)
18-Apr-2024 09:29 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1536.35
Dr. Reddys Lab 6070.00
Cipla 1374.55
Zydus Lifesciences 943.90
Lupin 1620.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.